PARPi in Ovarian Cancer: Beyond BRCA and HRD Status
Key Takeaways
- PARP inhibitors are effective in ovarian cancer
- Benefits extend beyond BRCA mutations
- HRD testing helps guide treatment
- Maintenance therapy improves outcomes
Who is this video for?
Questions to ask your doctor
- Should I be tested for BRCA mutations?
- Am I a candidate for PARP inhibitors?
- What is maintenance therapy?
Have questions about this topic?
Suchi can summarize key points and help you prepare questions for your doctor.
Ask Suchi about this video
